Drugs / Yufeng Ningxin
Yufeng Ningxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07607275 | May 2026 → Dec 2027 expected | essential hypertension | Beijing Anzhen Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yufeng Ningxin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07607275 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Yufeng Ningxin, a traditional Chinese medicine” NCT07607275 ↗ |